Jeffrey Riley
Director/Board Member presso GAIN THERAPEUTICS, INC.
Patrimonio netto: 113 100 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Jeffrey Riley
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Biotechnology | 16 | |
BlinkTBI, Inc.
 BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC.
7
| Holding Company | Data Processing Services | 7 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
CaraVan Biologix
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jeffrey Riley tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Rochester Christian University | College/University | Graduate Degree | |
| VERICEL CORPORATION | Pharmaceuticals: Major | Chief Administrative Officer Comptroller/Controller/Auditor | |
| 3I GROUP PLC | Investment Managers | Private Equity Investor | |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Public Communications Contact Sales & Marketing | |
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| MOLMED S.P.A. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Investment Managers | Corporate Officer/Principal | |
| George Washington University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Rush University | College/University | Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chairman Director/Board Member Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Barcelona | College/University | Doctorate Degree Doctorate Degree | |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal Sales & Marketing | |
| University of Bocconi | College/University | Undergraduate Degree Graduate Degree | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Xbio Systems, Inc.
 Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | Information Technology Services | Director/Board Member | |
| CRAFT 1861 GLOBAL HOLDINGS INC. | Director/Board Member | ||
The St. Raphael Healthcare System
 The St. Raphael Healthcare System Hospital/Nursing ManagementHealth Services The St. Raphael Healthcare System provides health care services. It serves the residents of New Haven, Connecticut, and surrounding areas. The company services include cardiac care, cancer treatment, orthopedic medicine, and neurological treatment. The company was founded in 1907 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Corporate Officer/Principal | |
Craft 1861 Global, Inc.
 Craft 1861 Global, Inc. Miscellaneous Commercial ServicesCommercial Services Part of CRAFT 1861 Global Holdings, Inc., Craft 1861 Global, Inc. engages in scientific research and development and provides technology services for healthcare. The private company is based in Albuquerque, NM. The CEO of the company is Robert Aranda. Craft 1861 Global was acquired by BGP Acquisition Corp. on February 28, 2023 for $530 million. | Miscellaneous Commercial Services | Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Sirius Healthcare Partners GmbH
 Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Investment Managers | Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 29 |
| Italia | 4 |
| Svizzera | 4 |
| Australia | 4 |
| Spagna | 3 |
Settori
| Health Technology | 22 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 4 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 168 |
| Corporate Officer/Principal | 91 |
| Chairman | 44 |
| Independent Dir/Board Member | 43 |
| Chief Executive Officer | 43 |
Contatti più connessi
| Insiders | |
|---|---|
| Harvey Schiller | 44 |
| Khalid Islam | 29 |
| Dov Goldstein | 28 |
| Hans-Peter Hasler | 28 |
| James Kuo | 24 |
| Eric Richman | 22 |
| Gwen Melincoff | 20 |
| Steven H. Kanzer | 18 |
| Matthias Alder | 18 |
| Nelson K. Stacks | 17 |
| Steven Shallcross | 17 |
| Claude Nicaise | 16 |
| Charles Ballantyne | 15 |
| Roberto de Ponti | 15 |
| Michael Martino | 14 |
- Borsa valori
- Insiders
- Jeffrey Riley
- Connessioni Società
